Published • loading... • Updated
GLP-1-Based Therapies as a Possible Therapy Option for Obesity and Resistant Hypertension
Summary by Deutsches Ärzteblatt
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Leipzig – GLP-1-based therapies could be an alternative to the guidance recommended fourth-line therapy with mineralocorticoid receptor antagonists (MRA) in people with overweight or obesity and resistant hypertension. New study results suggest this at the 18th Annual Meeting of the German Society for Nephrology...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
